5 Years of Muğla Experience in Real-Time MRI Fusion Prostate Biopsy
- Doç. Dr. Serdar Yalçın, 2021 yılında Muğla'daki ilk gerçek zamanlı MRI füzyon prostat biyopsisini gerçekleştirerek bölgede bu alanda teknolojik bir standart başlatmıştır.
- Multiparametrik MRI ve ultrason görüntülerini birleştiren bu yöntem, şüpheli odakların yüksek hassasiyetle hedeflenmesini sağlayarak tanı doğruluğunu artırmaktadır.
- Başarılı bir prostat tanısı için ileri teknolojinin yanı sıra, hekimin klinik tecrübesi ve hastaya özel biyopsi stratejisinin birleşimi kritik önem taşımaktadır.
İçerik yapay zeka ile optimize edilmiştir
Real-Time MRI Fusion Prostate Biopsy in Muğla: A Legacy of Scientific Expertise
The path to appropriate treatment for prostate cancer begins with an accurate diagnosis. Today, the ability to directly target suspicious areas identified on multiparametric prostate MRI during biopsy represents one of the most significant technological advances in urological diagnostics.
Assoc. Prof. Dr. Serdar Yalçın performed the first MRI fusion prostate biopsy in Muğla Province on October 16, 2021, at Acıbadem Bodrum Hospital. This milestone integrated his clinical and scientific expertise with Real-Time MRI/Ultrasound Fusion technology, bringing a new standard of care to the region. Since then, the program has continued uninterrupted, serving hundreds of patients as the only center providing this technology in Muğla.
The Evolution of Expertise: From 2015 to Today
Assoc. Prof. Dr. Serdar Yalçın’s experience with MRI-targeted prostate biopsy predates the first procedure in Bodrum. His journey with this technology began in 2015 at Gülhane Military Medical Academy, where he was part of the pioneering team introducing MRI fusion biopsy to Türkiye.
Key milestones in this clinical and scientific journey include:
- 2015: Commencement of MRI-targeted prostate biopsy applications at Gülhane.
- 2015–2021: Active clinical application and over 3,000 prostate biopsies performed.
- 2019: Publication of a major scientific study evaluating results from 344 patients, comparing standard biopsy with cognitive fusion-targeted biopsy.
- 2021: Integration of software-assisted Real-Time MRI/US fusion technology in Bodrum.
Why Is MRI Essential Before a Prostate Biopsy?
In modern urological practice, a prostate biopsy is no longer a blind procedure based solely on elevated PSA levels. Multiparametric prostate MRI has become a critical component of the diagnostic pathway.
The objective of a modern biopsy is to accurately sample the specific area identified as suspicious on MRI, rather than simply obtaining systematic tissue samples from predefined areas. This shift ensures that clinically significant prostate cancer is detected with higher precision.
Understanding Real-Time MRI Fusion Technology
Real-Time MRI/US Fusion Biopsy involves transferring a patient’s MRI images to a specialized biopsy system. During the procedure, the following steps occur:
- MRI Identification: The suspicious lesion is identified on pre-acquired MRI scans.
- Live Visualization: The prostate is visualized via ultrasound in real time.
- Software Registration: Specialized software fuses the MRI and live ultrasound images.
- Precision Targeting: The biopsy needle is directed precisely toward the fused target.
This method, often referred to as "pinpoint" or "precision-targeted" biopsy, allows for superior target visualization and standardization compared to traditional methods.
Cognitive Targeting vs. Real-Time MRI Fusion
It is important for patients to understand the distinction between these two targeting methods:
| Feature | Cognitive Targeting | Real-Time MRI/US Fusion |
|---|---|---|
| Method | Physician mentally maps MRI findings to ultrasound. | Software automatically registers and fuses images. |
| Technology | No computer-based image registration. | Dedicated software-assisted platform. |
| Visualization | Dependent on physician's mental interpretation. | Target is visible on the screen during the procedure. |
| Standardization | Highly dependent on anatomical experience. | Provides technological documentation and planning. |
While scientific evidence does not show a definitive superiority in overall cancer detection rates for software fusion over cognitive targeting, the technological support and visualization provided by Real-Time Fusion offer significant advantages in biopsy planning and execution.
The Role of Experience in Diagnostic Success
Technology is only one part of the equation; the second critical factor is operator experience. A high-quality biopsy requires a combination of:
- High-quality MRI imaging.
- Appropriate targeting technology.
- The correct biopsy strategy.
- Extensive clinical experience.
Assoc. Prof. Dr. Serdar Yalçın’s background, featuring over a decade of experience and thousands of procedures, ensures that the technology is utilized to its full potential for patient benefit.
Frequently Asked Questions About MRI-Targeted Biopsy
Does Every PI-RADS Lesion Require a Biopsy?
No. The decision to perform a biopsy is not based solely on the PI-RADS score. A comprehensive evaluation must include PSA density, prostate volume, digital rectal examination findings, family history, and age.
What Does "Pinpoint Biopsy" Actually Mean?
While the term suggests a single point, it actually refers to the accurate and sufficient sampling of a suspicious area. This may involve multiple samples from the lesion and the surrounding tissue to ensure diagnostic accuracy.
What Should You Do if Your MRI Shows a Lesion?
If a PI-RADS 3, 4, or 5 lesion is detected, the focus should be on whether the area can be accurately targeted. The goal is to identify cancer that may influence treatment decisions while avoiding unnecessary procedures.
Assoc. Prof. Dr. Serdar Yalçın
Urology Specialist
Bodrum / Muğla
Note: This article is for informational purposes. Biopsy indications and techniques must be determined individually for each patient.
